Skip to main content
PMC home page
Neuroscience Bulletin logoLink to Neuroscience Bulletin
. 2013 Oct 16;29(6):725–730. doi: 10.1007/s12264-013-1381-4

Synergistic effect of MTHFR C677T and F2 G20210A polymorphisms on ischemic stroke

Thierry Paluku They-They 1,2,✉, Omar Battas 1, Sellama Nadifi 2
PMCID: PMC5562548  PMID: 24132798

Abstract

The predisposition to stroke might involve interactive effects among variants in several genes. We tested this hypothesis by examining the influence of polymorphisms in methylenetetrahydrofolate reductase (MTHFR) (C677T) and prothrombin (F2) (G20210A) as risk factors for stroke in Morocco. The polymerase chain reaction-restriction fragment length polymorphism methods were used to analyze DNA from 91 stroke patients and 182 controls. Association between the two polymorphisms and the risk of stroke was estimated by four-level models for the analysis of genetic interaction. Neither the MTHFR 677TT nor the F2 20210GA genotype showed any significant association compared to the MTHFR CC and F2 GG genotypes, respectively. An interactive effect between the MTHFR 677TT and F2 20210GA polymorphisms showed an increased risk of stroke. The odds ratios, in univariate and multivariate analysis, for the combined polymorphisms were 4.99 (95% CI, 1.75–14.2, P = 0.001) and 5.29 (95% CI, 1.63–17.1, P = 0.005), respectively.

Keywords: genotyping, prothrombotic polymorphisms, risk factor, MTHFR, F2, stroke

References

  • [1].Flossman E, Schulz UGR, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004;35:212–227. doi: 10.1161/01.STR.0000107187.84390.AA. [DOI] [PubMed] [Google Scholar]
  • [2].Hassan A, Sham PC, Markus HS. Planning genetic studies in human stroke: sample size estimates based on family history data. Neurology. 2002;58:1483–1488. doi: 10.1212/WNL.58.10.1483. [DOI] [PubMed] [Google Scholar]
  • [3].Hassan A, Markus HS. Genetics and ischaemic stroke. Brain. 2000;123:1784–1812. doi: 10.1093/brain/123.9.1784. [DOI] [PubMed] [Google Scholar]
  • [4].Dichgans M. Genetics of ischemic stroke. Lancet Neurol. 2000;6:149–161. doi: 10.1016/S1474-4422(07)70028-5. [DOI] [PubMed] [Google Scholar]
  • [5].Pezzini A, Grassi M, Del Zotto E, Archetti S, Spezi R, Vergani V, et al. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke. 2005;36:533–539. doi: 10.1161/01.STR.0000155741.31499.c2. [DOI] [PubMed] [Google Scholar]
  • [6].Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113. doi: 10.1038/ng0595-111. [DOI] [PubMed] [Google Scholar]
  • [7].Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9. doi: 10.1161/01.CIR.93.1.7. [DOI] [PubMed] [Google Scholar]
  • [8].Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, et al. Factor V Leiden, prothrombin gene G20210A variant, and méthylènetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost. 2001;7:346–350. doi: 10.1177/107602960100700418. [DOI] [PubMed] [Google Scholar]
  • [9].McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, méthylènetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke. 2002;33:2351–2356. doi: 10.1161/01.STR.0000032550.90046.38. [DOI] [PubMed] [Google Scholar]
  • [10].They-They TP, Nadifi S, Rafai MA, Battas O, Slassi I. Methylenehydrofolate reductase (C677T) polymorphism and large artery ischemic stroke subtypes. Acta Neurol Scand. 2011;123:105–110. doi: 10.1111/j.1600-0404.2010.01348.x. [DOI] [PubMed] [Google Scholar]
  • [11].Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol. 2004;61:1652–1661. doi: 10.1001/archneur.61.11.1652. [DOI] [PubMed] [Google Scholar]
  • [12].Goracy I, CyryŁowski L, Kaczmarczyk M, Fabian A, Koziarska D, Goracy J, et al. C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects. J Appl Genet. 2009;50(1):63–67. doi: 10.1007/BF03195654. [DOI] [PubMed] [Google Scholar]
  • [13].Bentley P, Peck G, Smeeth L, Whittaker J, Sharma P. Causal relationship of susceptibility genes to ischemic stroke: Comparison to ischemic heart disease and biochemical determinants. PLoS One. 2010;5(2):e9136. doi: 10.1371/journal.pone.0009136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703. [PubMed] [Google Scholar]
  • [15].They-They TP, Battas O, Slassi I, Rafai MA, Katumbay DT, Nadifi S. Prothrombin G20210A and factor V Leiden polymorphisms in stroke. J Mol Neurosci. 2012;46(1):210–216. doi: 10.1007/s12031-011-9580-9. [DOI] [PubMed] [Google Scholar]
  • [16].Szolnoki Z, Somogyvari F, Kondacs A, Szabó M, Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol. 2002;49:1391–1397. doi: 10.1007/s00415-002-0848-4. [DOI] [PubMed] [Google Scholar]
  • [17].Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Danneberg J, Abbes AP, Bruggeman BJ, Engel H, Gerrits J, Martens A. Reliable genotyping of the G-20210A mutation of coagulation factor II (prothrombin) Clin Chem. 1998;44:349–351. [PubMed] [Google Scholar]
  • [19].Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scaff M, et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost. 2000;83:229–233. [PubMed] [Google Scholar]
  • [20].Munshi A, Aliya N, Jyothy A, Kaul S, Alladi S, Shafi G. Prothombin gene G20210A mutation is not a risk factor for ischemic stroke in a South Indian Hyderabadi Population. Thromb Res. 2009;124:245–247. doi: 10.1016/j.thromres.2008.09.013. [DOI] [PubMed] [Google Scholar]
  • [21].Xin XY, Song YY, Ma JF, Fan CN, Ding JQ, Yang GY, et al. Gene polymorphisms and risk of adult early-onset ischemic stroke: A meta-analysis. Thromb Res. 2009;124:619–662. doi: 10.1016/j.thromres.2009.07.007. [DOI] [PubMed] [Google Scholar]
  • [22].Duca F, Sacchi E, Tagliabue L, Tajoli E. C677T méthylènetetrahydrofolate reductase (MTHFR) mutation in stroke. Thromb Haemost. 1997;78:102. [PubMed] [Google Scholar]
  • [23].Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33:664–669. doi: 10.1161/hs0302.103625. [DOI] [PubMed] [Google Scholar]
  • [24].Szolnoki Z, Somogyvári F, Kondacs A, Szabó M, Fodor L, Bene J, et al. Evaluation of the modifying effects of unfavorable genotypes on classical clinical risk factors for ischaemic stroke. J Neurol Neurosurg Psychiatry. 2003;74:1615–1620. doi: 10.1136/jnnp.74.12.1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998;91:3562–3565. [PubMed] [Google Scholar]
  • [26].Aznar J, Mira Y, Vayá A, Corella D, Ferrando F, Villa P, et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost. 2004;91:1031–1034. doi: 10.1160/TH03-11-0690. [DOI] [PubMed] [Google Scholar]
  • [27].Botto N, Spadoni I, Giusti S, Ait-Ali L, Sicari R, Andreassi MG. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke. 2007;38:2070–2073. doi: 10.1161/STROKEAHA.106.480863. [DOI] [PubMed] [Google Scholar]
  • [28].Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, et al. Homocysteine, MTHFR 677C-T polymorphism, and risk of ischemic stroke: results of a metaanalysis. Neurology. 2002;59:529–536. doi: 10.1212/WNL.59.4.529. [DOI] [PubMed] [Google Scholar]
  • [29].Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate redictase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146:948–957. doi: 10.1016/S0002-8703(03)00519-2. [DOI] [PubMed] [Google Scholar]
  • [30].Stankovic S, Majkic-Singh N. Genetic aspects of ischemic stroke. Jugoslov Med Biohem. 2005;24:225–239. doi: 10.2298/JMB0504225S. [DOI] [Google Scholar]
  • [31].Doggen CJ, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation. 1998;97:1037–1041. doi: 10.1161/01.CIR.97.11.1037. [DOI] [PubMed] [Google Scholar]
  • [32].Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, et al. Synergistic effects of prothrombotic Smokers polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood. 1999;39:2186–2190. [PubMed] [Google Scholar]
  • [33].Franco RF, Trip MD, ten Cate H, van den Ende A, Prins MH, Kastelein JJ, et al. the 20210 G→A mutation in the 3-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol. 1999;104:50–54. doi: 10.1046/j.1365-2141.1999.01149.x. [DOI] [PubMed] [Google Scholar]
  • [34].Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis. BMJ. 2002;325:1202. doi: 10.1136/bmj.325.7374.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Samman S, Sivarajah G, Man JC, Ahmad ZI, Petocz P, Caterson ID. A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr. 2003;133:2188–2193. doi: 10.1093/jn/133.7.2188. [DOI] [PubMed] [Google Scholar]
  • [36].Biasi E. The effects of dietary choline. Neurosci Bull. 2011;27(5):330–342. doi: 10.1007/s12264-011-1523-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Lalouel JM, Rohrwasser A. Power and replication in casecontrol studies. Am J Hypertens. 2002;15:201–205. doi: 10.1016/S0895-7061(01)02285-3. [DOI] [PubMed] [Google Scholar]

Articles from Neuroscience Bulletin are provided here courtesy of Springer

RESOURCES